CompanyNasdaqRutherford, NJ

GlucoTrack, Inc

GlucoTrack develops a long-term implantable continuous blood glucose monitoring system for people with diabetes.

SEC EDGAR ClinicalTrials.gov

8-KSep 28Latest SEC filing

Form DMay 8$500K sold

September 2026

GlucoTrack amends multiple warrants and notes, removing floor price reduction terms

Sep 28PartnershipGlucoTrack, Inc

Glucotrack prices $3 million public offering of stock and pre-funded warrants

Sep 24FinancingGlucoTrack, Inc

Glucotrack director resigns citing conflict of interest, CEO details LT-100 plans

Sep 23PeopleGlucoTrack, Inc

Glucotrack stockholders approve Nasdaq-required share issuances at special meeting

Sep 14PartnershipGlucoTrack, Inc

August 2026

GlucoTrack files financials for merged Lokahi Therapeutics, flags going concern doubt

Aug 28M&AGlucoTrack, Inc

GlucoTrack amends stock purchase agreement with White Lion Capital

Aug 10PartnershipGlucoTrack, Inc

Glucotrack closes $5.5 million financing tied to bridge notes and PIPE deal

Aug 5FinancingGlucoTrack, Inc

July 2026

GlucoTrack amends note exchange terms, changes minimum price calculation date

Jul 29PartnershipGlucoTrack, Inc

Glucotrack completes business combination with Lōkahi Therapeutics

Jul 15PartnershipGlucoTrack, Inc